← Leaderboards
James E Crowe
Vanderbilt University Medical Center
$103,007,271
Attributed
$118,215,091
Total exposure
59
Grants
44
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $60.5M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$168,753,652 · 62
By mechanism
U19$94,648,663 · 13
R01$30,188,601 · 13
N01$16,999,520 · 3
U01$14,064,534 · 5
P01$3,196,266 · 2
P30$3,177,531 · 7
Top collaborators
- Michael S. Diamond22 shared
- Jens Meiler12 shared
- Ralph S Baric5 shared
- Alexander Bukreyev5 shared
- William B Klimstra4 shared
- Daved H Fremont2 shared
- Richard J. Kuhn2 shared
- Torben Schiffner1 shared
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesVaccinesBaseVirusHuman Monoclonal AntibodiesEpitopesCellsMonoclonal AntibodiesAntigensInfectionNeutralizing AntibodyStructureDesignResponseProteinsAffinityComplexLaboratoriesImmuneProgramsResearch PersonnelImmunityTechnologyBinding
Grant awards (200)
Machine Learning to Modulate Influenza Immunity$1,195,056
U01 · FY2025 · AI
ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSES$1,111,778
U01 · FY2025 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses$781,163
R01 · FY2025 · AI · contact PI
Bunyavirus and Picornavirus Pandemic Pathogen Preparedness (BP4) Center$38,056,004
U19 · FY2024 · AI · contact PI
Project 5: mAb Development Flaviviruses and Alphaviruses$5,594,501
U19 · FY2024 · AI · contact PI
Human monoclonal antibodies for hantaviruses$4,790,125
U19 · FY2024 · AI · contact PI
RP4: Monoclonal antibodies against henipaviruses, arenaviruses, and nairoviruses$4,640,497
U19 · FY2024 · AI · contact PI
Structure based design of trimer interface epitope focused universal influenza vaccines$1,205,696
U01 · FY2024 · AI · contact PI
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2$1,193,360
R01 · FY2024 · AI
Admin-Core$1,138,445
U19 · FY2024 · AI · contact PI
ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSES$1,101,100
U01 · FY2024 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses$798,435
R01 · FY2024 · AI · contact PI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization$666,668
N01 · FY2024 · AI · contact PI
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION: Modification for SARS-CoV2 Research$666,666
N01 · FY2024 · AI · contact PI
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION$666,666
N01 · FY2024 · AI · contact PI
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses$2,464,333
U19 · FY2023 · AI · contact PI
Structure based design of trimer interface epitope focused universal influenza vaccines$1,213,432
U01 · FY2023 · AI · contact PI
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2$1,197,841
R01 · FY2023 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses$810,278
R01 · FY2023 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$766,992
R01 · FY2023 · AI
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection$703,258
R01 · FY2023 · AI · contact PI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization$645,570
N01 · FY2023 · AI · contact PI
Project 2 - Vanderbilt University$556,676
U19 · FY2023 · AI · contact PI
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses$2,464,332
U19 · FY2022 · AI · contact PI
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION$2,000,000
N01 · FY2022 · AI · contact PI
Structure based design of trimer interface epitope focused universal influenza vaccines$1,221,071
U01 · FY2022 · AI · contact PI
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2$1,202,440
R01 · FY2022 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses$858,139
R01 · FY2022 · AI · contact PI
Project 2 - Vanderbilt University$802,301
U19 · FY2022 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$756,658
R01 · FY2022 · AI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization$645,570
N01 · FY2022 · AI · contact PI
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses$2,578,594
U19 · FY2021 · AI · contact PI
Structure based design of trimer interface epitope focused universal influenza vaccines$1,224,163
U01 · FY2021 · AI · contact PI
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2$1,206,220
R01 · FY2021 · AI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$758,862
R01 · FY2021 · AI
Human neutralizing antibodies for Zika virus$655,157
R01 · FY2021 · AI · contact PI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization$645,570
N01 · FY2021 · AI · contact PI
Project 2 - Vanderbilt University$554,565
U19 · FY2021 · AI · contact PI
PROJECT 4: Genetic and Structural Basis for Human Antibody Inhibition of Dengue Viruses$400,751
P01 · FY2021 · AI · contact PI
Flow Cytometry Shared Resource$126,489
P30 · FY2021 · CA · contact PI
FLOW CYTOMETRY CORE$70,335
P30 · FY2021 · DK · contact PI
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION: Modification for SARS-CoV2 Research$3,033,590
N01 · FY2020 · AI · contact PI
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses$2,775,679
U19 · FY2020 · AI · contact PI
Structure based design of trimer interface epitope focused universal influenza vaccines$1,265,006
U01 · FY2020 · AI · contact PI
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2$1,193,309
R01 · FY2020 · AI
Project 2 - Vanderbilt University$862,247
U19 · FY2020 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$769,175
R01 · FY2020 · AI
Human neutralizing antibodies for Zika virus$649,057
R01 · FY2020 · AI · contact PI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization$645,570
N01 · FY2020 · AI · contact PI
PROJECT 4: Genetic and Structural Basis for Human Antibody Inhibition of Dengue Viruses$415,529
P01 · FY2020 · AI · contact PI
Flow Cytometry Shared Resource$126,489
P30 · FY2020 · CA · contact PI
FLOW CYTOMETRY CORE$93,892
P30 · FY2020 · DK · contact PI
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses$2,736,269
U19 · FY2019 · AI · contact PI
Structure based design of antibodies and vaccines$2,688,754
U19 · FY2019 · AI · contact PI
Identification of novel human antibodies and vaccines against influenza$873,320
U19 · FY2019 · AI · contact PI
Project 2 - Vanderbilt University$862,247
U19 · FY2019 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$825,853
R01 · FY2019 · AI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs$721,808
R01 · FY2019 · AI · contact PI
Human neutralizing antibodies for Zika virus$644,482
R01 · FY2019 · AI · contact PI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Virus Neutralization$628,380
N01 · FY2019 · AI · contact PI
Immunology Core$452,720
P01 · FY2019 · AI · contact PI
IOF Core$425,547
U19 · FY2019 · AI · contact PI
FLOW CYTOMETRY CORE$97,275
P30 · FY2019 · DK · contact PI
Administrative core: Modeling Immunity for Biodefense Project coordination$89,859
U19 · FY2019 · AI · contact PI
Structure based design of antibodies and vaccines$2,610,482
U19 · FY2018 · AI · contact PI
GENETIC & STRUCTURAL BASIS FOR INFLUENZA VIRUS NEUTRALIZATION$1,350,000
N01 · FY2018 · AI · contact PI
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses$997,348
U19 · FY2018 · AI · contact PI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs$725,215
R01 · FY2018 · AI · contact PI
Identification of novel human antibodies and vaccines against influenza$664,850
U19 · FY2018 · AI · contact PI
Human neutralizing antibodies for Zika virus$632,282
R01 · FY2018 · AI · contact PI
Immunology Core$443,776
P01 · FY2018 · AI · contact PI
IOF Core$418,725
U19 · FY2018 · AI · contact PI
Flow Cytometry Shared Resource$104,317
P30 · FY2018 · CA · contact PI
FLOW CYTOMETRY CORE$94,618
P30 · FY2018 · DK · contact PI
Administrative core: Modeling Immunity for Biodefense Project coordination$85,386
U19 · FY2018 · AI · contact PI
Flow Cytometry Shared Resource$10,000
P30 · FY2018 · CA · contact PI
Flow Cytometry Shared Resource$7,998
P30 · FY2018 · CA · contact PI
Flow Cytometry Shared Resource$7,970
P30 · FY2018 · CA · contact PI
Flow Cytometry Shared Resource$4,818
P30 · FY2018 · CA · contact PI
Flow Cytometry Shared Resource$4,735
P30 · FY2018 · CA · contact PI
GENETIC & STRUCTURAL BASIS FOR INFLUENZA VIRUS NEUTRALIZATION$2,616,817
N01 · FY2017 · AI · contact PI
Structure based design of antibodies and vaccines$2,122,980
U19 · FY2017 · AI · contact PI
Human neutralizing antibodies for Zika virus$1,327,897
R01 · FY2017 · AI · contact PI
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses$953,424
U19 · FY2017 · AI · contact PI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs$728,541
R01 · FY2017 · AI · contact PI
Immunology Core$447,527
P01 · FY2017 · AI · contact PI
IOF Core$418,725
U19 · FY2017 · AI · contact PI
Identification of novel human antibodies and vaccines against influenza$353,251
U19 · FY2017 · AI · contact PI
Flow Cytometry Shared Resource$104,317
P30 · FY2017 · CA · contact PI
Administrative core: Modeling Immunity for Biodefense Project coordination$97,868
U19 · FY2017 · AI · contact PI
FLOW CYTOMETRY CORE$70,336
P30 · FY2017 · DK · contact PI
Structure based design of antibodies and vaccines$2,431,508
U19 · FY2016 · AI · contact PI
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses$1,099,053
U19 · FY2016 · AI · contact PI
IOF Core$682,128
U19 · FY2016 · AI · contact PI
Immunology Core$511,535
P01 · FY2016 · AI · contact PI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs$496,974
R01 · FY2016 · AI · contact PI
Identification of novel human antibodies and vaccines against influenza$277,541
U19 · FY2016 · AI · contact PI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs$234,811
R01 · FY2016 · AI · contact PI
Flow Cytometry Shared Resource$101,355
P30 · FY2016 · CA · contact PI
Administrative core: Modeling Immunity for Biodefense Project coordination$83,963
U19 · FY2016 · AI · contact PI
Flow Cytometry Core$68,957
P30 · FY2016 · DK · contact PI
Structure based design of antibodies and vaccines$2,169,626
U19 · FY2015 · AI · contact PI
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses$1,711,899
U19 · FY2015 · AI · contact PI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs$761,802
R01 · FY2015 · AI · contact PI
Immunology Core$524,428
P01 · FY2015 · AI · contact PI
IOF Core$395,948
U19 · FY2015 · AI · contact PI
Molecular Determinants of Cross-Reactive Antibody Response to Influenza in Humans$370,127
R01 · FY2015 · AI · contact PI
Identification of novel human antibodies and vaccines against influenza$279,854
U19 · FY2015 · AI · contact PI
Flow Cytometry Shared Resource$101,355
P30 · FY2015 · CA · contact PI
Administrative core: Modeling Immunity for Biodefense Project coordination$93,290
U19 · FY2015 · AI · contact PI
Flow Cytometry Core$68,957
P30 · FY2015 · DK · contact PI
Flow Cytometry Shared Resource$58,544
P30 · FY2015 · CA · contact PI
Molecular Determinants of Cross-Reactive Antibody Response to Influenza in Humans$20,128
R01 · FY2015 · AI · contact PI
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses$1,746,519
U19 · FY2014 · AI · contact PI
Hybrid Methods for Prediction and Design of Novel Human Influenza Antibodies$433,256
R56 · FY2014 · AI
Molecular Determinants of Cross-Reactive Antibody Response to Influenza in Humans$390,000
R01 · FY2014 · AI · contact PI
Human neutralizing monoclonal antibodies for Rift Valley fever virus$212,803
R21 · FY2014 · AI · contact PI
Virology Training Program$183,560
T32 · FY2014 · AI · contact PI
Flow Cytometry$162,418
P30 · FY2014 · CA · contact PI
Flow Cytometry Core$68,957
P30 · FY2014 · DK · contact PI
Genetic & structural basis for viral neutralization:Vaccinia and Influenza virus$1,704,968
N01 · FY2013 · AI · contact PI
Molecular Determinants of Cross-Reactive Antibody Response to Influenza in Humans$366,600
R01 · FY2013 · AI · contact PI
Genetic & structural determinants of neutralization of human mAbs to dengue virus$356,869
U54 · FY2013 · AI · contact PI
Human neutralizing monoclonal antibodies for Rift Valley fever virus$249,996
R21 · FY2013 · AI · contact PI
Virology Training Program$181,606
T32 · FY2013 · AI · contact PI
Flow Cytometry$155,388
P30 · FY2013 · CA · contact PI
Flow Cytometry Core$58,597
P30 · FY2013 · DK · contact PI
Genetic & structural basis for viral neutralization:Vaccinia and Influenza virus$1,083,485
N01 · FY2012 · AI · contact PI
Clonal Analysis of the Human B Cell Response to HIV$573,245
U01 · FY2012 · AI · contact PI
Molecular Determinants of Cross-Reactive Antibody Response to Influenza in Humans$390,000
R01 · FY2012 · AI · contact PI
Genetic & structural determinants of neutralization of human mAbs to dengue virus$339,939
U54 · FY2012 · AI · contact PI
Virology Training Program$181,642
T32 · FY2012 · AI · contact PI
Flow Cytometry$83,617
P30 · FY2012 · CA · contact PI
Flow Cytometry Core$68,957
P30 · FY2012 · DK · contact PI
Clonal Analysis of the Human B Cell Response to HIV$587,547
U01 · FY2011 · AI · contact PI
Genetic & structural determinants of neutralization of human mAbs to dengue virus$322,888
U54 · FY2011 · AI · contact PI
Virology Training Program$179,776
T32 · FY2011 · AI · contact PI
Flow Cytometry$84,582
P30 · FY2011 · CA · contact PI
Flow Cytometry Core F$78,740
P30 · FY2011 · DK · contact PI
Clonal Analysis of the Human B Cell Response to HIV$599,877
U01 · FY2010 · AI · contact PI
Multi-Laser Flow Cytometer for Polychromatic Analysis$482,490
S10 · FY2010 · RR · contact PI
Genetic & structural determinants of neutralization of human mAbs to dengue virus$379,686
U54 · FY2010 · AI · contact PI
Rotavirus VP6 Specific Human IgA Antibodies$193,750
R21 · FY2010 · AI · contact PI
Flow Cytometry$91,881
P30 · FY2010 · CA · contact PI
Virology Training Program$88,981
T32 · FY2010 · AI · contact PI
Flow Cytometry Core F$88,259
P30 · FY2010 · DK · contact PI
Clonal Analysis of the Human B Cell Response to HIV$51,307
U01 · FY2010 · AI · contact PI
Clonal Analysis of the Human B Cell Response to HIV$7,750
U01 · FY2010 · AI · contact PI
Clonal Analysis of the Human B Cell Response to HIV$882,141
U01 · FY2009 · AI · contact PI
Clonal Analysis of the Human B Cell Response to HIV$605,938
U01 · FY2009 · AI · contact PI
Rotavirus VP6 Specific Human IgA Antibodies$232,500
R21 · FY2009 · AI · contact PI
Genetic & structural determinants of neutralization of human mAbs to dengue virus$159,480
U54 · FY2009 · AI · contact PI
Flow Cytometry Core F$79,902
P30 · FY2009 · DK · contact PI
Clonal Analysis of the Human B Cell Response to HIV$619,313
U01 · FY2008 · AI · contact PI
Monoclonal Antibody and Biosensor Core$386,015
U54 · FY2008 · AI · contact PI
Alphavirus-based Vaccine for Prevention of MPV Infection$383,336
R01 · FY2008 · AI · contact PI
FLOW CYTOMETRY & CELL SORTING SHARED RESOURCE$226,711
P30 · FY2008 · CA · contact PI
Respiratory Syncytial Virus Nanoparticle Vaccines$185,029
R21 · FY2008 · AG · contact PI
Flow Cytometry Core F$80,933
P30 · FY2008 · DK · contact PI
HUMAN T CELL RESPONSES TO RSV$187
M01 · FY2008 · RR · contact PI
Human Antibody Responses to Rotavirus$357,938
R01 · FY2007 · AI · contact PI
Alphavirus-based Vaccine for Prevention of MPV Infection$306,083
R01 · FY2007 · AI · contact PI
FLOW CYTOMETRY & CELL SORTING SHARED RESOURCE$219,096
P30 · FY2007 · CA · contact PI
Alphavirus-based Vaccine for Prevention of MPV Infection$166,625
R01 · FY2007 · AI · contact PI
Respiratory Syncytial Virus Nanoparticle Vaccines$157,338
R21 · FY2007 · AG · contact PI
Flow Cytometry Core F$77,828
P30 · FY2007 · DK · contact PI
Alphavirus-based Vaccine for Prevention of MPV Infection$59,900
R01 · FY2007 · AI · contact PI
HUMAN T CELL RESPONSES TO RSV$3,979
M01 · FY2007 · RR · contact PI
Human Antibody Responses to Rotavirus$368,629
R01 · FY2006 · AI · contact PI
Human T Cells Responses to RSV$331,767
R01 · FY2006 · AI · contact PI
Alphavirus-based Vaccine for Prevention of MPV Infection$315,812
R01 · FY2006 · AI · contact PI
Cell-Mediated Immune Responses to Vaccinia Viruses$284,256
R01 · FY2006 · AI · contact PI
FLOW CYTOMETRY & CELL SORTING SHARED RESOURCE$78,569
P30 · FY2006 · CA · contact PI
HUMAN T CELL RESPONSES TO RSV$13,003
M01 · FY2006 · RR · contact PI
Human Antibody Responses to Rotavirus$377,500
R01 · FY2005 · AI
Human T Cells Responses to RSV$339,750
R01 · FY2005 · AI
Novel methods for generation of human B cell hybridomas$339,750
R01 · FY2005 · AI
Alphavirus-based Vaccine for Prevention of MPV Infection$336,592
R01 · FY2005 · AI
Cell-Mediated Immune Responses to Vaccinia Viruses$290,637
R01 · FY2005 · AI
FLOW CYTOMETRY &CELL SORTING SHARED RESOURCE$76,281
P30 · FY2005 · CA
High Throughput Flow Cytometry Sorter$459,207
S10 · FY2004 · RR
Cell-Mediated Immune Responses to Vaccinia Viruses$447,732
R01 · FY2004 · AI
Novel methods for generation of human B cell hybridomas$381,250
R01 · FY2004 · AI
Human Antibody Responses to Rotavirus$377,500
R01 · FY2004 · AI
Human T Cells Responses to RSV$339,750
R01 · FY2004 · AI
HIGH THROUGHPUT FLOW CYTOMETRY SORTER: IMMUNOLOGY$270,932
S10 · FY2004 · RR
HIGH THROUGHPUT FLOW CYTOMETRY SORTER: INFECTIOUS DISEASE$91,841
S10 · FY2004 · RR
Immunomodulation on the Nanoscale (RMI)$75,500
PN1 · FY2004 · EY
FLOW CYTOMETRY &CELL SORTING SHARED RESOURCE$74,058
P30 · FY2004 · CA
HIGH THROUGHPUT FLOW CYTOMETRY SORTER: AIDS$59,697
S10 · FY2004 · RR
Epitope Specificity of RSV Nucleoprotein-Specific T Cel*$40,320
R03 · FY2004 · TW
HIGH THROUGHPUT FLOW CYTOMETRY SORTER: AUTOIMMUNE DISEASE$36,737
S10 · FY2004 · RR
Novel methods for generation of human B cell hybridomas$339,750
R01 · FY2003 · AI
Cell-Mediated Immune Responses to Vaccinia Viruses$164,288
R01 · FY2003 · AI
Human T Cells Responses to RSV$157,125
R01 · FY2003 · AI
Epitope Specificity of RSV Nucleoprotein-Specific T Cel*$40,320
R03 · FY2003 · TW
Novel methods for generation of human B cell hybridomas$327,000
R01 · FY2002 · AI
HUMAN MONOCLONAL ANTIBODIES THAT NEUTRALIZE VACCINIA$198,893
U01 · FY2002 · AI
Epitope Specificity of RSV Nucleoprotein-Specific T Cel*$40,320
R03 · FY2002 · TW
ONTOGENY OF RSV-SPECIFIC B CELL RESPONSES IN HUMANS$231,167
R01 · FY2001 · HD